Search research articles
Contact Us
Filters
Showing results (61-70 of 164) with videos related to
Page
of 17
Sort By:
Drugs & Aging
|
February 23, 2022
The FORTA (Fit fOR The Aged) List 2021: Fourth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults
Farhad Pazan, Christel Weiss, Martin Wehling, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
March 26, 2003
Non-genomic aldosterone action: from the cell membrane to human physiology
Ralf Lösel, Martin Feuring, Martin Wehling
Steroids
|
January 31, 2012
Nongenomic actions of aldosterone and progesterone revisited
Alexandra Wendler, Christian Albrecht, Martin Wehling
European Journal of Clinical Pharmacology
|
January 27, 2019
A systematic review and novel classification of listing tools to improve medication in older people
Farhad Pazan, Jonathan Kather, Martin Wehling
Drugs & Aging
|
June 6, 2022
Correction to: The FORTA (Fit fOR The Aged) List 2021: Fourth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults
Farhad Pazan, Christel Weiss, Martin Wehling, et al.
Drugs & Aging
|
October 21, 2025
The FORTA (Fit for the Aged) List 2024: Fifth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults
Farhad Pazan, Christel Weiss, Martin Wehling, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
May 13, 2008
Proteins interact with the cytosolic mineralocorticoid receptor depending on the ligand
Miriam Weber, Martin Wehling, Ralf Lösel
Drugs & Aging
|
May 2, 2023
The EURO-FORTA (Fit fOR The Aged) List Version 2: Consensus Validation of a Clinical Tool for Improved Pharmacotherapy in Older Adults
Farhad Pazan, Christel Weiss, Martin Wehling, et al.
Healthcare (Basel, Switzerland)
|
July 26, 2024
Neurexan Prescription Is Associated with Lower Risk of Sleep Disorder Recurrence and Depression Prevalence as Compared to Z-Drugs and Benzodiazepines: A Retrospective Database Analysis in Germany
Göran Hajak, Céline Vetter, Martin Wehling
Clinical and Experimental Pharmacology & Physiology
|
September 3, 2011
Dalteparin dose-dependently increases ROTEM(®) thrombelastography parameters only at supratherapeutic anti-factor Xa levels: an in vitro study
Martin Feuring, Martin Wehling, Armin Schultz
Page
of 17
Search research articles
Search
Showing results (61-70 of 164) with videos related to
Sort By:
Page
of 17
Drugs & Aging
|
February 23, 2022
The FORTA (Fit fOR The Aged) List 2021: Fourth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults
Farhad Pazan, Christel Weiss, Martin Wehling, et al.
The Journal of Steroid Biochemistry and Molecular Biology
|
March 26, 2003
Non-genomic aldosterone action: from the cell membrane to human physiology
Ralf Lösel, Martin Feuring, Martin Wehling
Steroids
|
January 31, 2012
Nongenomic actions of aldosterone and progesterone revisited
Alexandra Wendler, Christian Albrecht, Martin Wehling
European Journal of Clinical Pharmacology
|
January 27, 2019
A systematic review and novel classification of listing tools to improve medication in older people
Farhad Pazan, Jonathan Kather, Martin Wehling
Drugs & Aging
|
June 6, 2022
Correction to: The FORTA (Fit fOR The Aged) List 2021: Fourth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults
Farhad Pazan, Christel Weiss, Martin Wehling, et al.
Drugs & Aging
|
October 21, 2025
The FORTA (Fit for the Aged) List 2024: Fifth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults
Farhad Pazan, Christel Weiss, Martin Wehling, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
May 13, 2008
Proteins interact with the cytosolic mineralocorticoid receptor depending on the ligand
Miriam Weber, Martin Wehling, Ralf Lösel
Drugs & Aging
|
May 2, 2023
The EURO-FORTA (Fit fOR The Aged) List Version 2: Consensus Validation of a Clinical Tool for Improved Pharmacotherapy in Older Adults
Farhad Pazan, Christel Weiss, Martin Wehling, et al.
Healthcare (Basel, Switzerland)
|
July 26, 2024
Neurexan Prescription Is Associated with Lower Risk of Sleep Disorder Recurrence and Depression Prevalence as Compared to Z-Drugs and Benzodiazepines: A Retrospective Database Analysis in Germany
Göran Hajak, Céline Vetter, Martin Wehling
Clinical and Experimental Pharmacology & Physiology
|
September 3, 2011
Dalteparin dose-dependently increases ROTEM(®) thrombelastography parameters only at supratherapeutic anti-factor Xa levels: an in vitro study
Martin Feuring, Martin Wehling, Armin Schultz
Page
of 17